Swing Therapeutics was founded in 2019 with the goal of developing digital treatments in disease areas where patients are not well-served, and where digital interventions may be effective. Its focus is on tackling autoimmune conditions and chronic overlapping pain conditions (COPCs) like fibromyalgia where central pain sensitization is a significant factor. The company is investing in research to support the development and validation of its pipeline of prescription-based digital therapies. Swing Therapeutics’ near-term goal is to validate its digital program for the treatment of fibromyalgia and bring it to market as an FDA-cleared, prescription-based digital therapeutic.
Company Details
Swing Therapeutics, Inc. Questions
Swing Therapeutics, Inc.'s website is https://www.swingtherapeutics.com
Swing Therapeutics, Inc.'s LinkedIn profile is https://www.linkedin.com/company/swing-therapeutics
Swing Therapeutics, Inc. has
22 employees.
View email and phone details for 22
employees at Swing Therapeutics, Inc..
Swing Therapeutics, Inc.'s industry is
Biotechnology Research
Swing Therapeutics, Inc.'s top competitors are
Bitterroot Bio,
Wonderfeel Biosciences,
Panacro,
Tierra Biosciences,
Marin Biologic Laboratories,
Evercrisp Biosciences,
Nudge,
Gate Bioscience,
Glycomine Inc.,
Karyon Bio.
Swing Therapeutics, Inc.'s categories are Biotechnology Research
Swing Therapeutics, Inc.'s founding year is 2019
